Revenue and profit rose sharply in H1 FY 2026, driven by robust product sales and royalty income. The company is on track to meet full-year forecasts, with a record number of regulatory filings and strong pipeline progress, including Fast Track status for AQUA07.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.